Your SlideShare is downloading. ×
  • Like
Division of Cardiology
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Division of Cardiology

  • 1,077 views
Published

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
1,077
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
5
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. The Quarterly Newsletter - Fall 2006 Newsletter of the Leon H. Charney Division of Cardiology With great excitement we bring you this first issue of our Division of Cardiology Newsletter. Published quarterly, the Newsletter will provide information on the activi- ties and accomplishments of the faculty, fellows, staff and friends of the Leon H. Char- ney Division of Cardiology. Our plan is to distribute the Newsletter electronically via email and also post it on our website at: www.med.nyu.edu/medicine/cardiology. Each issue will provide a mix of features, including news items, announcements, clinical trial updates, awards and recognitions and listings of new grants, publications and presenta- tions. We hope this information will be of interest to many of you and welcome your feedback and suggestions for topics to include in future issues! We also are looking for a name for the Newsletter! Contact us at: cardiology@med.nyu.edu. Many thanks to Brian Sullivan, Abena Palmore, Erika Laurion, Carl Glenn and Gary Sokolow for making this project a reality. - Glenn I. Fishman, M.D., Director, Division of Cardiology In This Issue Smilow Center Opening Fellows Featured Clinical Trials New Translational Research Update on our trainees Testing Novel Therapies Center Houses Cardiovascular Page 3 Page 6 Biology Program Page 2 New Faces in the Division Clinical Update Profiles of New Faculty and Staff in Focus on Cardiac Rehabilitation our Division Page 9 Page 4 Grants Corner Honoring our Benefactors Electronic Submission Luncheon Presentations Discuss “The Page 10 biomedical Revolution and a Healthy Heart.” Page 6 New Awards and Honors Accomplishments of colleagues in the Division of Cardiology Page 11 1
  • 2. The Quarterly Newsletter - Fall 2006 Smilow Research Center Opening With the recent comple- cular disease in our popu- tion of the Joan and Joel lation, scientists in Smilow Smilow Research Center, are focusing their efforts basic and translational on studies that will lead to investigators within NYU’s improved diagnosis, pre- Division of Cardiology vention and treatment of and Cardiovascular Biol- clinically relevant disor- ogy Program have con- ders including arrhyth- solidated their research mias, heart failure and vas- programs in one location. cular disease. Currently Housed on the 8th floor four research groups are of he new Joan and Joel located on the 8th floor in Smilow Translational Re- the new building led by search Bulding, with recruitment efforts ongoing to fill Principal Investigators Drs. Glenn I. Fishman, Edward A. the 7th floor as well, investigators enjoy a a state-of-the- Fisher, David E. Gutstein and Gregory E. Morley. Addi- art research center with expansive views of the East Side tional information on the Smilow Center can be found at: of Manhattan. Given the enormous burden of cardiovas- www.med.nyu.edu/smilowcenter/. Research Programs EDWARD A. FISHER, MD, PhD GLENN I. FISHMAN, MD Dr. Edward A. Fisher, Director of the Marc and Ruti Bell Dr. Glenn I. Fishman, Director of the Leon H. Charney Vascular Biology and Disease Program. His major areas of Division of Cardiology. His laboratory is interested in focus are mechanisms related to risk factors causing understanding cardiovascular development and disease. A coronary artery disease. His group spans the range of major focus of the laboratory is elucidating the nature of cell-free systems to mouse models and use modern cardiac excitability, including the molecular genetic basis techniques of cellular and molecular biology. Recent pa- of conduction system development and function, as well pers have highlighted their work in novel pathways regu- as the molecular patho- lating hepatic lipo- physiology of cardiac ar- protein secretion as rhythmias. The laboratory well as atheroscle- utilizes a multi-disciplinary rosis regression. In approach, combining mo- addition to the lecular biology, electro- laboratory program, physiology and genetically Dr. Fisher also leads modified mouse model a clinical research systems. program in risk fac- tor reduction. 2
  • 3. The Quarterly Newsletter - Fall 2006 DR. DAVID E. GUTSTEIN DR. GREGORY E. MORLEY Dr. David E. Gutstein is an Assistant Professor in the Dr. Gregory E. Morley, also an Assistant Professor, has the Leon H. Charney Division of Cardiology and holds a joint long rang goal of determining the mechanisms of impulse appointment as an Assistant Professor in the Department initiation and conduction and the role they play in trig- of Cell Biology. In his laboratory, he is investigating car- gering and maintaining cardiac arrhythmias. In the labora- diac pathophysiology using mutant mouse models and tory, high speed imaging techniques are used to visualize other experimental electrical wave propagation at both the macroscopic and techniques. He is cellular levels. Ongoing studies are directed at identifying interested in the the major determinants of conduc- basic pathways and tion heterogeneities commonly as- mechanisms under- sociated with cardiovascular disease. lying cardiac devel- Ultimately, a better understanding of opment and func- the processes that govern cardiac tion and how these conduction will lead to fundamen- pathways become tally new directions for the treat- disrupted in dis- ment of malignant cardiac arrhyth- ease states. mias. Fellows The graduating fellows from our Cardiovascular Disease Fellowship entering Class of 2003 have all remained at NYU for additional years of training. Renato Apolito, Kevin Steinberg and Loran Yehudai began their training in Interventional Car- diology. Ania Garlitski, Jad Swingle as well as Scott Bernstein began training in Clinical Cardiac Electrophysiology. Lenny Yatskar has joined us as an Attending in the Division of Cardiology’s Interventional Cardiology Program. We extend a very special welcome to our new fellows, who began their training on July 1, 2006. Eleni Doufekias Mark D. Fisch Zev B. Frankel Susie Hong Cornell Medical Center Boston Medical Center Mount Sinai Hospital Mount Sinai Hospital Eugene Kim Louis H. Miller William S. Shin Adam H. Skolnick Boston Medical Center New York University Yale-New Haven Beth Israel Deaconess 3
  • 4. The Quarterly Newsletter - Fall 2006 New Faces in the Division of Cardiology Jennifer H. Mieres, M.D., F.A.C.C., F.A.H.A, the PBS documentary “A Woman’s Heart,” for which she F.A.S.N.C. joins the faculty as an Associate Professor was nominated for an Emmy for Best documentary in the of Medicine and the Director of Nuclear Cardiology at Health Science category at the 46th Annual New York NYU Medical Center. A gradu- Emmy Awards held in March 2003. ate of Bennington College and Boston University School of David E. Cohen, M.D. joined our cardiology faculty Medicine, Dr. Mieres completed her training in Internal Medi- in July 2006 as the Director of the new NYU Program in cine, Cardiology and Nuclear Critical Limb Ischemia. Dr. Cohen obtained his medical Cardiology at St Luke’s Roose- degree from Columbia University, completed his medical velt Medical Center in New residency at the University of Michigan, a cardiology fel- York City. She was the Director lowship at Albert Einstein College of Medicine, and an of Nuclear Cardiology at North interventional cardiology fellowship at New York Medical Shore University Hospital in College in Valhalla, NY. Ten years ago he took a sabbatical Long Island New York from at St. Elizabeth’s Medical Center in Boston under 1995 to June, 2006. Drs. Jeffrey Isner and Ken- neth Rosenfield in periph- Dr. Mieres is a Fellow of the American College of Physi- eral vascular intervention. cians, American College of Cardiology, the American He is Board Certified in Heart Association (AHA) and American Society of Nu- Cardiovascular Diseases clear Cardiology and is board certified in cardiovascular and Interventional Cardi- diseases and nuclear cardiology. Her clinical research ology and also in Endovas- interests include women and heart disease and the role cular Medicine by the of cardiac imaging in the diagnosis and risk assessment of newly created American coronary disease. She is one of the principle investigators Board of Vascular Medicine. of the ongoing multi-center diagnostic trial “The WOMEN.” Since that time, while in practice at St. Joseph’s Regional Medical Center in Paterson, NJ, Dr. Cohen has applied Dr. Mieres has been a member of the invited faculty at many newly emerging endovascular technologies to a the Scientific Sessions for the American Heart Associa- wide variety of challenging vascular conditions such as tion and American College of Cardiology. She is a found- multi-level peripheral arterial disease, long occlusions, and ing member of the American Society of Nuclear Cardiol- complex tibial occlusive disease. These endovascular ogy and is the Vice President elect of that society. modalities include laser angioplasty, advanced atherec- Dr. Mieres is also actively involved with the AHA on a tomy procedures, and stenting. Dr. Cohen has been an local and national level and is a nation spokesperson, past active investigator in a variety of research protocols in- member of the national board of Directors, and is the cluding the LACI-2 trial for laser angioplasty in critical Chair of the Cardiac Imaging Committee of the Council limb ischemia, and the LEAP trial which is applying ad- of Clinical Cardiology for that organization. She is a vanced plaque analysis after atherectomy procedures. Dr. member of the national AHA’s Nominating Committee, Cohen’s passion for peripheral arterial disease manage- Strategic Planning Task force and Professional Education ment has led to a transition in his practice from coronary Committee. Dr. Mieres is the immediate past president of to peripheral arterial disease, founding Circulatory Care the AHA’s Long Island Region and is the Secretary of the of New Jersey. He has also embraced an endovenous AHA’s local Heritage Affiliate. Dr. Mieres also serves as approach for the treatment of symptomatic venous in- the Chair of the Scientific Advisory Board for Women sufficiency and has also founded the Center for Advanced Heart (the national coalition for women living with heart Vein Therapy in New Jersey. disease). She is a recipient of the 2002 New York State The NYU Program in Critical Limb Ischemia is aimed at Governor’s award for excellence and as a producer of building upon the existing endovascular/peripheral vascu- 4
  • 5. The Quarterly Newsletter - Fall 2006 lar program in the cardiac catheterization laboratory, Dr.Yatskar’s research interest focus on the topic of pioneered by Drs. Michael Attubato and Anvar Babaev. Coronary Artery and Peripheral Vascular Disease man- The program will focus on treating patients with claudi- agement. He is a co-investigator in the ACUITY, OAT, cation and with critical limb ischemia. Dr. Cohen will DYNAMIC Registry, SHOCK 11, BIAMI and STRADI- help to develop teaching programs and research oppor- VARIUS Clinical Trials. tunities in vascular disease and atherosclerosis. He will be working closely with the current cath lab faculty to bring this exciting program to fruition. Office consulta- Ms. Diana Levyatova CPC recently joined the staff tions are available through the cardiac catheterization of the Division of Cardiology as the Billing Coordinator laboratory. & Coder for NYU Cardiac Catheterization Associates. Prior to joining the Division of Cardiology she was em- ployed as a Coder/ Biller for the Stamford and Green- Victor Navarro, M.D. joined our cardiology faculty wich Hospital Systems. Diana recently became a Certi- earlier this year as an Assistant Professor of Medicine. fied Professional Coder (CPC) and she is fluent in four Born in Havana, Cuba, Dr. Navarro grew up in Caracas, languages (Russian, Ukranian, Polish and English). Venezuela. In 1984 he graduated magna cum laude from the Central University of Venezuela School of Medicine, where he obtained his Physician-Surgeon degree.  He Ms. Jamie Wright CPC also joined our staff in April ranked first in his class. Dr. Na- 2006. Jamie is working as the Billing Coordinator/Coder varro came to New York in for the Nuclear Stress Lab and the Cardiac Rehab Pro- 1986 where he completed his gram. Prior to joining the Division of Cardiology, Jamie internship, and subsequently his worked as the Team Leader for the Center for Weight residency and Cardiology fel- Loss Surgery at Danbury Hospital and before that she lowship at the Long Island Col- worked for Continuum Health Partners for over 7 years, lege Hospital (LICH) in 1989 in several different capacities including the Practice Man- and 1991, respectively.  Finally ager of a Large Multi-Specialty practice. Jamie is also a he completed his Invasive Car- certified Professional Coder with over ten years experi- diology fellowship at Maimoni- ence in the healthcare field. des Medical Center in 1992. Ms. Erika Laurion, MS, joined the staff of the Leon H. Charney Division of Cardiology in May 2006. Erika is Dr. Navarro has been in clinical practice in the area of working as an Executive Assistant to the Clinical Cardio- Brooklyn since 1992.  In 1999 he joined the LICH Divi- vascular Research Program. Prior to joining the Division sion of Cardiology where he held the position of Direc- of Cardiology, Erika worked as an Administrator of the tor of the Exercise and Electrocardiography Labs. In May Division of Cardiology at Beth Israel Medical Center. 2006, he joined the NYU Division of Cardiology as Assis- Erika has a M.S. from the Institute of Human Nutrition at tant Professor. He is currently committed to expanding the College of Physicians and Surgeons, Columbia Uni- the Brooklyn and Manhattan NYU Faculty Group Prac- versity and a B.A. in Business from SUNY. tice. We are also please to announce that Ms. Nadine Birbalsingh has joined the Heart Failure Program staff Leonid Yatskar, M.D., has joined the faculty of the as Drs. Jorde and Vittorio’s Administrative Assistant; Ms. Division of Cardiology Faculty in July 2006 as an inter- Rachel Chao Wang has joined the Cardiovascular ventional cardiologist. Dr.Yatskar recently completed his Research Staff as a Research Coordinator; Mr. Victor fellowship training at NYU in Interventional Cardiology Joaquin, Research Technician has joined Dr. Edward this past June 2006. He is boarded in both in Internal Fisher’s Research Staff; Mr. Marc Ponzio, Research Medicine and Cardiovascular Disease. Technician has joined Dr. David Gutstein’s Research Staff Dr.Yatskar is currently working in a practice in Brooklyn, and Ms. Miriam Cohen-Navarro (Office Mgr), Ms. as well as holding a staff physician in the Catheterization Claudia Irving (Medical Assistant), Ms. Rosa She- Laboratories at Bellevue Hospital Center and Elmhurst hoah (FGP Assistant) and Ms. Katya Amirov Hospital in Queens. (Sonographer) have joined the Division of Cardiology Staff as part of Dr. Navarro’s Brooklyn and 14th Street Manhattan Office Staff. 5
  • 6. The Quarterly Newsletter - Fall 2006 Celebration Luncheon to Honor Our Friends! Each spring, NYU Medical Center holds a luncheon to recognize and thank the many friends who have to supporting this institu- tion. Invited to this elegant event are the John Revere Society members who have included the Medical Center in their estate plans, and the 1841 Society members who have made annual do- nations of $5,000 or more. This year, the luncheon took place on May 8, 2006, at the Regency Hotel on Park Avenue and 61st Street and honored our very own Leon H. Charney whose extraor- dinarily generous philanthropy led to the naming of our Division of Cardiology in his honor in 2001 (pictured here with Drs. Kal- man, Fisher and Fishman). The theme for the luncheon was “Take Heart.” The event featured an informative presentation on cardiovascular biology and medicine entitled: “Of Mice and Men, and Women Too: The Biomedical Revolution and a Healthy Heart.” Leading the presentation was Glenn I. Fishman, whose topic was “Cardiovascular biology and medicine – translating discovery into healthy hearts at NYU.” Also participating was Edward A. Fisher, M.D., Ph.D., the Leon H. Charney Professor of Cardio- vascular Medicine, who spoke about lowering your risk of heart disease and putting the good cholesterol to work. Jill Kalman, M.D., Associate Professor of Medicine and Chief, Cardiac Service, Tisch Hospital and Director, Cardiomyopathy Program, discussed the topic “Success with heart failure: a survival guide for the weak at heart.” At NYU Medical Center, our donors are truly the heart of our institution. Our donors enable our doctors to dis- cover new cures, to provide the most progressive, compassionate care to our patients, and to utilize the most modern, technologically advanced equipment. We are proud to share some of the remarkable advances that have been taking place in NYU’s Leon H. Charney Division of Cardiology – achievements that would not have been possible without the dedication and generosity of our wonderful friends. Featured Clinical Trials Currently there are 50 open trials in the Division of Cardiology. Below we highlight four of these, with plans to focus on additional trials in subsequent issues of the Newsletter. We encourage you to consider enrolling ap- propriate patients in these and other active clinical trials. Please contact the appropriate coordinator for each study with any questions you may have. You can also join our Cardiology Research Conferences every Wednesday at noon at Bellevue Hospital. Contact Erika.laurion@nyumc.org for more info. CUE HF PI - Harmony Reynolds, MD Coordinator: Karen Hager pager 917 812 9070 The goal of this study is to determine the utility of measurement of carotid intimal-medial thickness in the diagnosis of obstructive coronary artery disease as the etiology of dilated cardiomyopathy. Why we should enroll? To support this investigator initiated study funded by a grant from the New York Cardiac Center Foundation.Very easy study to enroll. One additional test for patient. 6
  • 7. The Quarterly Newsletter - Fall 2006 Fellows are critical in identifying patients. Coordinator will do the rest by enrolling the patient and schedule for carotid ultrasound. This test was previously not available at Bellevue and is now as of ~ June 19, 2006. Major inclusion: • Cardiomyopathy (EF ≤ 40%) of uncertain cause • Scheduled for coronary angiography Major Exclusion: • Patients will be excluded if they are known to have severe CAD • History of myocardial infarction. EVEREST PI – James Slater, MD Coordinator: Karen Hager- pager 917 812 9070 A study of the Evalve Cardiovascular Valve Repair System (CVRS) Endovascular Valve Edge-to-Edge REpair Study. Phase II evaluation of the safety and effectiveness of an endovascular approach to the treatment of mitral valve regurgita- tion using the Evalve Cardiovascular Valve Repair System. Why we should enroll? First pivotal study of its kind. Help NYU become a leader in the NYC community for study enrollment. Very competi- tive site selection (Columbia and Cornell are also sites). So far 1 patient was rolled in (not randomized, received clip) one patient scheduled for second roll-in. A fellow has referred a patient who was screened but not randomized. Many fellows probably see eligible patients who may not be aware of the study and may be interested and eligible. Patients are randomized 2:1 for clip or surgery respectively. Major inclusion: • Mod to severe (3+) or severe (4+) chronic mitral valve regurgitation • Symptomatic with > 25% LVEF or Asymptomatic with (call contact for specifics) • Candidate for mitral valve repair or replacement surgery, including cardiopulmonary bypass. Major Exclusions • Evidence of an acute MI <12 weeks of the intended treatment • The need for any other cardiac surgery including surgery for CAD, atrial fibrillation, pulmonic, aortic or tricuspid valve disease. TACT PI – Harmony Reynolds, MD Coordinator: Karen Hager- pager 917 812 9070 Is chelation therapy/vitamin therapy safe and effective for treatment of cardiovascular disease (in combination with tradi- tional treatments)? Why we should enroll? To prove or disprove use of chelation to treat CAD and because it is a NIH/NCCAM funded study that needs a boost in enrollment. Patients have 30 weekly infusions followed by 10 monthly infusions. Open label low-dose vitamins throughout infusion period and double blind high dose/placebo vitamins throughout study and follow up. Infusions are done by RN at the General Clinical Research Center, Bellevue Hospital 8E. Travel compensation given to patients. 7
  • 8. The Quarterly Newsletter - Fall 2006 Total enrolled at NYU to date: 7 Total enrolled in all sites: 991 Major Inclusions: • >50 • Previous MI Major Exclusions: • Stage II hypertension • Inability to tolerate weekly fluid load of 500cc • Smoking • Planned revascularization FIX-HF-5 PI – Jill Kalman, MD Coordinator: Christine Surach, NP: 212 263 3134 A study of the Evaluation and Efficiency of the Optimizer System with Active Fixation Leads in Subjects with Heart Fail- ure Resulting from Systolic Dysfunction: FIX- HF-5 This is a randomized Phase II investigational device clinical trial for patients with moderate to severe heart failure, and normal width QRS on EKG. Sponsor is Impulse Dynamics. Why we should enroll? Over the past decade the use of pacemakers and devices for patients with heart failure has exploded, most importantly, with the widespread adoption of Cardiac Resynchronization Therapy and Defibrillators. However, it is estimated that less than half our patients with advanced heart failure have a prolonged QRS and these patients are therefore not indicated for the benefits of resynchronization devices. This present clinical trial evaluates the efficacy of a new investigational im- planted device designed to treat patients with chronic heart failure and a normal QRS duration. The investigational de- vice is the OPTIMIZER III System; by Impulse Dynamics. This system delivers non-excitatory cardiac contractility modula- tion (CCM) signals. These signals are intended to enhance the influx of calcium and thus influence myocardial properties in patients with chronic heart failure, and improve outcomes. The objective of this study is to evaluate the effects of the device on exercise and quality of life endpoints, as well as mortality. Phase I safety has been completed without overt safety concerns. NYU is one of 50 enrolling sites in the US. Thus far, 1 patient has been enrolled at NYU and implanted with the Optimizer device on June 7, 2006. Major inclusions: • Treatment of heart failure for at least 90 days, including beta-blocker • Appropriate stable medical therapy for heart failure • EF of 35% or less • NYHA class III or IV • QRS 120ms or less Major Exclusions: • VO2 max less than 9% • Prior heart transplant • MI or CABG less than 90 days, PTCA less than 30 days • Atrial Fibrillation • PR interval greater than 275 ms • Mechanical tricuspid or aortic valves • Implanted Bi-Ventricular device, or with a clinical indication for Bi-V 8
  • 9. The Quarterly Newsletter - Fall 2006 Clinical Update: Cardiac Rehabilitation In March of 2006, Medicare published a national decision memorandum that extends coverage for outpatient cardiac re- habilitation to several new groups of patients who have had stent placement and heart valve repair and replacement. This is an opportunity for this specific patient subgroup to NOW take advantage of the comprehensive services provided at the NYUMC Joan and Joel Smilow Cardiac Rehabilitation and Prevention Center at the Rusk Institute of Rehabilitation Medicine. The following information elaborates on the process of referral to the outpatient cardiac rehabilitation pro- gram.   OUTPATIENT PROGRAM ENROLLMENT CRITERIA Entry criteria include diagnoses that are reimbursed by the patient’s insurance carrier.  The following are usually accepted diagnoses: • Myocardial infarction within one year • Coronary bypass surgery within one – two years • Stable angina documented by a stress test Effective March 22nd, 2006 Medicare expanded outpatient coverage to include • Heart valve repair/replacement • Percutaneous transluminal coronary angioplasty (PTCA)/ coronary stenting   Most private insurance carriers and Medicare will cover 80 – 100% of the cost of the outpatient cardiac rehabilitation program under major medical plans.  Other diagnoses may be acceptable to insurance carriers as well and will be re- viewed on an individual basis.   ENROLLMENT • Referral letter from his/her primary physician or consulting cardiologist documenting the cardiac history and need for cardiac rehabilitation therapy • A medical prescription which states the diagnosis, date of onset and the recommendation for 36 cardiac sessions of monitored outpatient cardiac rehabilitation • Lipid profile analysis (Total cholesterol, HDL, LDL, and Triglycerides) • Cardiac stress test within 3 months of the start of the program • Supplemental laboratory information: echocardiogram, cardiac catheterization and Holter reports   EXERCISE CLASS STRUCTURE  Each patient will have an individual exercise prescription plan.  During the exercise hour, the patient will exercise 15 minutes on three exercise modalities with suggestions for use of specific modalities.  The Cardiologist and the Exercise Physiologist will monitor the aerobic progress at intervals during the 36 sessions with recommendations to adjust the patient’s target heart rate and exercise workload.  Prior to completion of the program, each patient will schedule an exit interview with the Cardiac Rehabilitation Physiatrist to review the patient’s coronary risk diary and with the Exercise Physiologist who will customize an exercise discharge plan in relation to the patient’s particular performance.  The circuit weight-training program is designed to recondition and improve muscular strength and endurance through- out the entire musculoskeletal system.  In combination with the aerobic component of our program, this will allow pa- tients to further maximize their functional independence and overall quality of life.  The weight-training program is moni- tored and supervised by the Physiatrist, Physical Therapist and Exercise Physiologist.  After 12 monitored exercise ses- sions, if the patient is an appropriate candidate, one exercise modality will be substituted with a 15 – minute weight- training sessions.   9
  • 10. The Quarterly Newsletter - Fall 2006 CORONARY RISK FACTOR EDUCATION CLASSES  A schedule of the coronary risk factor education classes will be given to the individual at the intake interview.  These classes are presented in a 12 weekly topic cycle and are offered three times per week.  The classes cover various topics from the benefits of exercise to stress management techniques.  The classes are highly encouraged for all individuals with coronary risk factors such as hypertension, diabetes, high cholesterol, and obesity. An individual, who is interested in the program, may call 212-263-HEART between the hours of 9:00 am and 5:30 p.m., Monday – Friday to schedule an appointment with the Cardiac Rehabilitation Physiatrist and the Advance Practice Nurse.   Mariano Rey, MD Jonathan Whiteson, MD Ana Mola,MA,RN,ANP-C Co-Medical Director Co-Medical Director Program Director Grants Corner: Electronic Submission Welcome to the Grants Corner, which will be a regular feature of the Newsletter. The purpose of this segment is to provide cardiovascular researchers and investigators within the Division of Cardiology information on grants, including recent changes at the National Institutes of Health, funding opportunities, newly received grants and other relevant grant news. This inaugural column will look at the NIH’s transition to electronic submission of grants and its impact on the submis- sion process. As of February 1, 2007, all R01 grants will move to electronic submission and, as of June 1, 2007, all K awards will move to electronic submission. Electronic submission will involve a number of changes to grant applications that I will cover in future columns. For now, it is important that researchers and investigator register with the NIH’s eRA Commons, if they have not already. You can do this by contacting Saadia Malik at NYU’s Sponsor Programs Administration office at extension 3-8151. One of the largest changes for electronic submissions is that the institution—and not the investigator—submits the grant electronically. At NYU, SPA will submit all electronic grants. Final versions of grants will need to be ready for sub- mission and given to SPA at least a week before the final deadline. Paper deadlines enabled an investigator to receive early signoff from SPA, continue to work on the grant until the final deadline, and then send it out. The timing of elec- tronic submissions will not allow for this and, in essence, the deadline for completed grants will now be a week before the final due date. The Department of Medicine is in contact with SPA and training sessions on electronic submission are being planned.You can also reach out to SPA individually. If you have any questions about any item in this column or need assistance with a grant, you can contact me at 3-4127 or at gary.sokolow@nyumc.org. 10
  • 11. The Quarterly Newsletter - Fall 2006 New Awards /Honors Itzhak Kronzon, MD (pictured here in a very recent photograph) was re- nominated senior professor by special appointment at Tel Aviv University, Israel. He also received the Distinguished Teaching Award from the Indian Academy of Echocar- diography, was elected as a Fellow of the European Society of Cardiology (FESC) and was appointed a member of the editorial board of the Journal of the European Jour- nal of Echocardiography. Last summer, he was appointed an honorary member of the Venezuelan Cardiology Society. and in other news from the Non-Invasive Lab..... Gila Perk, 3rd year fellow in cardiology received the career development award from the American Soci- ety of Echocardiography. This most prestigious award was in support of her project Echocardiographic Evaluation of Chest Pain in the ER. Lana Choy-Shan, a 2nd year medical resident was the winner of the New York Echocardiography Society Joan Barber competition for the best presentation in clinical echocar- diography. The topic presented was: Automatic calculation of Global LV Function by Non Doppler Speckle imaging. Edward Fisher, MD, PhD Jennifer Mieres, MD was was awarded a second NIH elected as a Fellow of the RO1 award for the study of American Heart Association and Regression of Atherosclerosis Chair of the National Cardiac and Diabetes. Imaging Committee of the Clini- cal Council of Cardiology and Incoming Vice President of the American Society of Nuclear Cardiology. Harmony Reynolds, MD received a Doris Duke Charitable Foundation Clinical Scientist Development Award. Daniel Fisher MD was She was also recently Elected as a Fellow of the elected to fellowship American Society of Nuclear in the American Col- Cardiology. lege of Cardiology and the American Society of Echocardiography. 11
  • 12. The Quarterly Newsletter - Fall 2006 Judith Hochman, MD Mark Lipton, MD was appointed by NHLBI Direc- awarded a $300,000 NIH tor to the Executive Com- Grant award to develop a mittee to Co-Chair of the plan for a regional health Strategic Planning Clinical Tri- Information Exchange. als Working Group. She was also named to the Editorial Boards of the following jour- nals: Acute Cardiac Care, Circulation, American Heart Journal and Critical Pathways Mariano Rey, MD was in Cardiology. named Director of the NYU Institute for Community Health and Research and has recently received a $3.5 mil- lion grant from New York City for the NYC Hepatitis Program. Congratulations to all of these individuals for their achievements! If you have good news to share with the Division, please forward it to cardiology@med.nyu.edu and we will include it in the next is- sue of our Newsletter. Faces in the Crowd! 12